Press Release OMG LOL

Quote






anonymous said:
So nobody should do business with a company with a low stock value or market cap? Hmmmm...ever take an economics class? Again, I think not.
Click to expand...
You think not because you don't think. Management has made false promises to employees about future plans. Fact. Company has tried to clinically tie Natesto's intranasal administration to unproven safety. Fact. Sales haven't met projections because no one wants to put a gel in their nose for a chronic issue. Fact. The stock price is a direct reflection of the perceived worth of the company. Fact. You are believe you know more than anyone else. Fact. You don't. Fact. Aytu is a 3rd rate company peddling drugs they buy at a discount because they haven't sold well elsewhere and then hope to use stale marketing practices in order to gain enough traction to turn a measly profit. Fact. They never will. Fact.
 






anonymous said:
You think not because you don't think. Management has made false promises to employees about future plans. Fact. Company has tried to clinically tie Natesto's intranasal administration to unproven safety. Fact. Sales haven't met projections because no one wants to put a gel in their nose for a chronic issue. Fact. The stock price is a direct reflection of the perceived worth of the company. Fact. You are believe you know more than anyone else. Fact. You don't. Fact. Aytu is a 3rd rate company peddling drugs they buy at a discount because they haven't sold well elsewhere and then hope to use stale marketing practices in order to gain enough traction to turn a measly profit. Fact. They never will. Fact.
Click to expand...
Um...just so ya know, you can’t call a potential future event a “fact”. Also, ever hear of “shorting”. It actually inversely reflects the “ perceived worth of a company”. There is no pharma rating system that has “3rd rate” as category. Unless you have spoken to every patient, you can’t say “no one wants to put a gel in their nose....”. The phase 3 presents all the safety needed for any claims. You are hilarious. If you are a rep for AYTU...you may be correct about that 3rd rate thing.
 






anonymous said:
You think not because you don't think. Management has made false promises to employees about future plans. Fact. Company has tried to clinically tie Natesto's intranasal administration to unproven safety. Fact. Sales haven't met projections because no one wants to put a gel in their nose for a chronic issue. Fact. The stock price is a direct reflection of the perceived worth of the company. Fact. You are believe you know more than anyone else. Fact. You don't. Fact. Aytu is a 3rd rate company peddling drugs they buy at a discount because they haven't sold well elsewhere and then hope to use stale marketing practices in order to gain enough traction to turn a measly profit. Fact. They never will. Fact.
Click to expand...
Not to mention selling off label! Fact. Or using non fda approved clinical posters to detail doctors, fact. Such a shit show company. Fact. Lying to reps is common practice here. Fact. Wait until the FDA catches on
 






anonymous said:
Um...just so ya know, you can’t call a potential future event a “fact”. Also, ever hear of “shorting”. It actually inversely reflects the “ perceived worth of a company”. There is no pharma rating system that has “3rd rate” as category. Unless you have spoken to every patient, you can’t say “no one wants to put a gel in their nose....”. The phase 3 presents all the safety needed for any claims. You are hilarious. If you are a rep for AYTU...you may be correct about that 3rd rate thing.
Click to expand...
Keep believing. Keep denying. Keep being the person no one wants to interact with.
 


































































Top Bottom
Back
Quote